Latest filing published 09 Apr 2026 for Clover Biopharmaceuticals, Ltd. - B.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -35.4%Entry HK$2.85 · Close 05 Oct 2026 HK$1.84
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Farrow Jeffrey Stewart: trading record in brief
Farrow Jeffrey Stewart is a declared insider of Clover Biopharmaceuticals, Ltd. - B (chief executive), with filings sourced from HKEX. Over a trading history stretching from 5 November 2021 to 2 April 2026, the count stands at 13 filings.
Purchases make up the whole of the open-market record (5 purchases). No amount is published for 5 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 1 purchase and no sales.
The record was last updated on 9 April 2026 with a transaction in Clover Biopharmaceuticals, Ltd. - B. The clock since the last published purchase (1 April 2026) now reads 222 days. The median gap between a trade and its publication by HKEX is 5 days. Until a filing is published, the market cannot know about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to Farrow Jeffrey Stewart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 49,000 sharesShareXHKGHKEX:DA20260409E00120
- 340,000 sharesShareXHKGHKEX:DA20260401E00054Canonical exit: 25 Jun 2026 (T+90)
2 of 2 declarations
